medigraphic.com
SPANISH

Revista Médica de Costa Rica y Centroamérica

Colegio de Medicos y Cirujanos República de Costa Rica
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2015, Number 616

<< Back Next >>

Rev Med Cos Cen 2015; 72 (616)

Manejo de las convulsiones eclámpticas

Rojas CM
Full text How to cite this article

Language: Spanish
References: 11
Page: 545-550
PDF size: 153.07 Kb.


Key words:

No keywords

ABSTRACT

Eclampsia is a complication of rare but serious pregnancy, affects 1 in 2000 births in Europe and 1 in 1700 births in low- and middle-income causing 10% of maternal deaths11. It is characterized by tonicclonic seizures manifest as not related to brain conditions; their pathophysiological mechanisms remain unknown and although there are several theories that talk about the functional disorder of multiple organ systems none have been proven. Summarized and supports the main management postulating eclamptic seizures based on the importance of the use of magnesium sulfate for the prevention and control of this disease.


REFERENCES

  1. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 33: Diagnosis and Management of Preeclampsia and Eclampsia. Obstet Gynecol. 2002; 99:159-167.

  2. Braunwald E, Isselbacher KJ, Petersdorf RG, Wilson JD, Martin JB, Fauci AS, editors Harrison: Principios de Medicina Interna. 17 ed. Mexico: Interamericana; 2009. 2498-2500.

  3. Duley L, Henderson Smart D. Sulfato de magnesio versus fenitoína para la eclampsia. Base de Datos Cochrane de Revisiones Sistemáticas 2003, Issue 4. No.: CD000128. DOI: 10.1002/14651858.CD000128.

  4. Gabbe Steven G, Niebyl Jennifer R, Simpson Joe L.; Obstetricia. 4 ed en español. España: Marbán Libros 2004. 974-983.

  5. Garg Amit X.; Lam Ngan N.; et al.; Gestational Hypertension and Preeclampsia in Living Kidney Donors, N Eng J Med 2015, 372; 2.

  6. Gizat M. Kassie, Dereje Negussie and Jemal H. Ahmed. Maternal outcomes of magnesium sulphate and diazepam use in women with severe pre-eclampsia and eclampsia in Ethiopia. Pharmacy Practice; 12(2); 0-0; 2014-06.

  7. Hernández Núñez J, Valdés Yong M, Chong León L, González Medina IM, García Soto MM. Resultados perinatales en gestantes con bajo peso pregestacional. Rev Cubana Obstet Ginecol. 2013;39(2):76-86.

  8. Huarte M., Modroño A.; Larrañaga C.; Conducta ante los estados hipertensivos del embarazo, An. Sist. Sanit. Navar. 2009; 32 (Supl. 1): 91-103.

  9. LeFevre ML, on behalf of the U.S. Preventive Services Task Force. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2014;161: 819-26.

  10. Medina-Malo C. Epilepsia: clasificación para un enfoque diagnóstico según etiología y complejidades. Rev Neurol 2010; 50 (Supl 3): S25-30.

  11. Mostello D, Jen Chang J, Allen J, Luehr L, Shyken J, Leet T. Recurrent preeclampsia: the effect of weight change between pregnancies. Obstet Gynecol. 2010;116 (3):667-72.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Cos Cen. 2015;72